Aspen gets Canadian nod for generic GLP-1 pen – but flags supplier snag | News24

news24.com
منذ 10 ساعات
Aspen Pharmacare shares lifted 4% on Monday, after the company announced it had received approval for its generic injectable semaglutide in Canada.